Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price fell 1.6% during mid-day trading on Tuesday . The company traded as low as $68.92 and last traded at $70.85. 3,358,029 shares changed hands during trading, a decline of 52% from the average session volume of 7,004,383 shares. The stock had previously closed at $72.00.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on TEM. BTIG Research began coverage on shares of Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 price target on the stock. Wolfe Research lowered shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Morgan Stanley boosted their price target on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. JPMorgan Chase & Co. lowered Tempus AI from an "overweight" rating to a "neutral" rating and upped their price objective for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Finally, Piper Sandler lifted their target price on Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a report on Thursday, May 15th. Six research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $63.42.
Read Our Latest Stock Report on Tempus AI
Tempus AI Price Performance
The stock has a fifty day simple moving average of $58.73 and a 200-day simple moving average of $52.74. The company has a market capitalization of $11.83 billion and a PE ratio of -8.76. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45.
Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business's revenue was up 75.4% on a year-over-year basis. Equities analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
Insider Activity
In other news, Director Wayne A.I. Frederick sold 3,000 shares of the business's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the sale, the director now directly owns 26,514 shares of the company's stock, valued at approximately $1,207,447.56. The trade was a 10.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Andrew Polovin sold 17,552 shares of Tempus AI stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $63.43, for a total value of $1,113,323.36. Following the transaction, the executive vice president now directly owns 138,877 shares in the company, valued at approximately $8,808,968.11. This trade represents a 11.22% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 609,897 shares of company stock worth $41,397,783. Corporate insiders own 27.60% of the company's stock.
Hedge Funds Weigh In On Tempus AI
Institutional investors have recently modified their holdings of the business. Victory Capital Management Inc. acquired a new position in Tempus AI in the 4th quarter valued at about $216,000. Wells Fargo & Company MN increased its holdings in shares of Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after purchasing an additional 278 shares during the period. SeaCrest Wealth Management LLC purchased a new stake in shares of Tempus AI during the first quarter worth approximately $535,000. ProShare Advisors LLC acquired a new stake in shares of Tempus AI during the fourth quarter worth $244,000. Finally, Avanza Fonder AB lifted its holdings in shares of Tempus AI by 15.8% during the first quarter. Avanza Fonder AB now owns 41,005 shares of the company's stock worth $2,047,000 after purchasing an additional 5,591 shares during the period. 24.22% of the stock is owned by institutional investors and hedge funds.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
